Full text PDF - International Policy Network

Dr. Henry I. Miller joined the Food and Drug Administration in 1979and served in a number of posts. He was the medical reviewer forthe first genetically engineered drugs evaluated by the FDA and wasinstrumental in the rapid licensing of human insulin and humangrowth hormone. Thereafter, he was a special assistant to the FDAcommissioner, with responsibility for biotechnology issues, andfrom 1989 to 1993 was the founding director of the FDA’s Office ofBiotechnology. After leaving government service, Miller became theRobert Wesson Fellow in Scientific Philosophy and Public Policy atthe Hoover Institution, 1994–96.Professor Paul Reiter is a British scientist who has devoted hisentire career to the epidemiology of mosquito-borne diseases. Hisreputation for original research and innovative solutions broughthim to the US, where he worked for 22 years as a researcher in theDivision of Vector-borne Infectious Diseases of the Centers forDisease Control and Prevention. In 2003 he was appointed Professorat the Institut Pasteur, Paris, where he is in the process of establishinga new unit of Insects and Infectious Disease.CFD partner organisationsAction Research on Community Health, Gujarat, IndiaAIDS Responsibility Project, San Francisco, USAEuropean Coalition of Positive People, London, UKFree Market Foundation, Johannesburg, South AfricaFundacion DL, Bogota, ColombiaThe Global Bioscience Development Institute, USAImani: The Centre for Humane Education, Accra, GhanaInter Region Economic Network, Nairobi, KenyaInstitute for Public Policy Analysis, Lagos, NigeriaLiberty Institute, New Delhi, India